Cargando…
2769. Treatment of Hypermutator Pseudomonas aeruginosa Induces Multidrug Resistance but Can Be Targeted by Combination Therapy
BACKGROUND: Up to 60% of Pseudomonas aeruginosa (Pa) strains isolated from human chronic lung infections lack an active DNA mismatch repair (MMR) system, resulting in a hypermutator phenotype. Hypermutator Pa isolates are associated with enhanced multidrug resistance and treatment failure, and treat...
Autores principales: | Hall, Kalen M, Wimley, William C, Bojanowski, Christine M, Pursell, Zachary F, Morici, Lisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677162/ http://dx.doi.org/10.1093/ofid/ofad500.2380 |
Ejemplares similares
-
2167. Mutational Signature Analysis to Predict Drug-resistant Pseudomonas aeruginosa
por: Hall, Kalen M, et al.
Publicado: (2023) -
The role of the Pseudomonas aeruginosa hypermutator phenotype on the shift from acute to chronic virulence during respiratory infection
por: Hall, Kalen M., et al.
Publicado: (2022) -
2769. The Clinical and Economic Impact of MMR Vaccinations to Prevent Measles Importations from US Pediatric Travelers Returning from Abroad
por: Hyle, Emily P, et al.
Publicado: (2019) -
547. Multidrug-Resistant Pseudomonas aeruginosa in an Academic Regional Burn Intensive Care Unit
por: Estelle, Carolee D, et al.
Publicado: (2019) -
2385. Ceftazidime–Avibactam in Combination With Fosfomycin: A Novel Therapeutic Strategy Against Multidrug-Resistant Pseudomonas aeruginosa
por: Papp-Wallace, Krisztina M, et al.
Publicado: (2018)